EB
Erkut Bahceci
Hematology
Credentials: ·
Research
Gilteritinib or Chemotherapy for Relapsed or Refractory FLT3-Mutated AML
New England Journal of Medicine · 2019 · 1,078 citations
New England Journal of Medicine · 2000 · 797 citations
Blood · 1999 · 444 citations
- AB
8 papers

7 papers
- RC
7 papers

6 papers
- ML
6 papers
- NY
5 papers
- SL
5 papers

4 papers



